- AmerisourceBergen Corporation (Holding Co) stock price today and history
AmerisourceBergen Corporation (Holding Co) (ABC) stock prices updated...
Please, Signup (Login) to subscribe or trade (demo)
AmerisourceBergen Corporation (Holding Co) stock price
AmerisourceBergen Corporation (Holding Co) latest news:
BRIEF-AmerisourceBergen Prices $750 Mln 3.45 Pct Senior Notes Due 2027
* AMERISOURCEBERGEN PRICES $750 MILLION 3.45% SENIOR NOTES
2027 AND $500 MILLION 4.30% SENIOR NOTES DUE 2047
Source text for Eikon:
Further company coverage:
UPDATE 1-AmerisourceBergen to pay $625 mln to settle U.S. government probe
Nov 21 (Reuters) - A unit of AmerisourceBergen Corp,
one of the largest U.S. drug wholesalers, has agreed to pay $625
million to resolve a U.S. government probe involving pre-filled
syringes, the company said in a filing with U.S. securities
regulators on Tuesday.
AmerisourceBergen to buy drug wholesaler H.D. Smith for $815 mln
AmerisourceBergen Corp(ABC) said on Monday it would buy privately held U.S. drug wholesaler H. D. Smith for $815 million in cash. AmerisourceBergen (ABC), which plans to fund the deal through long-term debt issuance, expects the transaction to slightly add to its adjusted earnings per share in the current fiscal year.
AmerisourceBergen to acquire H.D. Smith for $815 million
AmerisourceBergen Corp. said late Monday it agreed to acquire independent wholesaler H.D. Smith for $815 million cash. The pharmaceuticals distributor, which plans to issue long-term debt for the deal, said it expects the acquisition to add slightly to earnings in fiscal 2018, and now expects revenue to grow by 8% to 11%. AmerisourceBergen said it expects the acquisition to add about 15 cents a share to earnings in fiscal 2020. Analysts surveyed by FactSet expect full-year fiscal 2018 earnings of $6.06 a share and revenue of $164.94 billion, a 7.7% increase from the previous year. The company expects the deal to close in early 2018. AmerisourceBergen shares were flat at $77.46 after hours.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
BRIEF-AmerisourceBergen to acquire H. D. Smith
* AmerisourceBergen Corp - plans to fund acquisition
issuance of new long-term debt
Amazon homing in on medical devices/supplies, not pharma: Jefferies
The possibility of online retailer Amazon.com Inc. entering the pharmaceutical industry has sent the stocks of drug distributors and pharmacy-benefit managers quaking in recent months, but a new report from Jefferies analysts suggests that Amazon is instead homing for the medical devices and supplies industries. Correspondence between two state pharmacy boards and Amazon reveals that those state licenses can only be used for medical device and supplies distribution, the Jefferies report said, based on information that was obtained through a Freedom of Information Act request. This direction was likely chosen to avoid "the more comprehensive regulatory requirements associated with the Wholesale Drug Distribution Act," Jefferies analyst Brian Tanquilut said. That has created an overhang on stocks like AmerisourceBergen Corp. , Cardinal Health Inc. , McKesson Corp. , Express Scripts Holding Co. , CVS Health Corp. and Walgreens Boots Alliance Inc. ; "Unfortunately, we believe only time will refute these investor concerns," he said. Amazon shares have surged 15% over the last three months, compared with a 4.5% rise in the S&P 500 and a 6.6% rise in the Dow Jones Industrial Average .Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
UPDATE 3-AmerisourceBergen expects tumbling generic drug prices to settle
* Shares initially rise, before reversing course
(Adds details on forecast, CEO and analyst comments; updates
AmerisourceBergen profit beats on higher cancer drug sales
* Beats on cancer products sales. * Takes $575 mln hit from litigation. * Forecasts 7-9 pct revenue growth for 2018. Drug distributor AmerisourceBergen Corp (ABC) reported a slightly better-than-expected quarterly profit, helped by higher sales of cancer drugs, and forecast revenue to grow as much as 9 percent in 2018. Shares of the company rose 4.4 percent to $80.00 in light premarket trading.
Drug stocks drop after report that Amazon has obtained pharmacy licenses
The stocks of companies in the pharmaceutical supply chain dropped in Thursday afternoon trade after a report by the St. Louis Post-Dispatch that online retailer Amazon has obtained approval to become a wholesale distributor in a number of states. Amazon has received approval in at least 12 states, the St. Louis Post-Dispatch reported. Speculation about an Amazon pharmacy entry has swirled since a CNBC report on the subject earlier this year, but Amazon has repeatedly declined to comment on or confirm any interest in pharmacy. Such a move would likely threaten a number of industry players, including drug wholesalers, pharmacy chains and pharmacy-benefit managers, middlemen that negotiate drug prices. Rite Aid Corp. shares dropped 5.6% in Thursday afternoon trade, CVS Health Corp. shares dropped 4.8%, Express Scripts Holding Company shares dropped 3.5%, McKesson Corp. shares dropped 3.4%, AmerisourceBergen Corp. shares dropped 4.4%, Walgreens Boots Alliance shares dropped 3.7% and Cardinal Health Inc. shares dropped 2.5%, compared with a 0.2% rise in the S&P 500 . Many of the stocks have plunged in the last several months on concerns about Amazon. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
Amira Nature Foods LtdANFI
AMN Healthcare Services IncAHS
Amplify Snack BrandsBETR
AmTrust Financial ServicesAFSI^A
AmTrust Financial ServicesAFSI^B
AmTrust Financial ServicesAFSI^C